Gamma/delta TAC T-cell therapy (Triumvira Immunologics/McMaster University)

N/A

Report date: 2025/01/26 17:50:12

Base Information

Drug NameGamma/delta TAC T-cell therapy (Triumvira Immunologics/McMaster University)

Drug Alias Namegamma/delta T cells with the T-cell antigen coupler receptor therapynext-gen TAC (Triumvira Immunologics/McMaster University)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTriumvira Immunologics Inc

China Registration ClassN/A

Develop Information

Active CompaniesTriumvira Immunologics Inc

Inactive CompaniesMcmaster University

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A